# Tacrolimus During the Implantation and the Effect on Ischemia-reperfusion Injury in Liver Transplantation

> **NCT00609388** · PHASE4 · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 26 (estimated)

## Conditions studied

- Ischemia Reperfusion Injury

## Interventions

- **DRUG:** Tacrolimus
- **OTHER:** Saline solution 0.9% (250mL)

## Key facts

- **NCT ID:** NCT00609388
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 26 (ESTIMATED)
- **Last updated:** 2010-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00609388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00609388, "Tacrolimus During the Implantation and the Effect on Ischemia-reperfusion Injury in Liver Transplantation". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00609388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*